The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
The Heme Oxygenase-1/Carbon Monoxide Pathway Suppresses TLR4 Signaling by Regulating the Interaction of TLR4 with Caveolin-1
Open accessAbstract
Caveolin-1 (cav-1), the principle structural protein of plasmalemmal caveolae, regulates inflammatory signaling processes originating at the membrane. We show that cav-1 bound to TLR4 and inhibited LPS-induced proinflammatory cytokine (TNF-α and IL-6) production in murine macrophages. Mutation analysis revealed a cav-1 binding motif in TLR4, essential for this interaction and for attenuation of proinflammatory signaling. Cav-1 was required for the anti-inflammatory effects of carbon monoxide (CO), a product of heme oxygenase-1 (HO-1) activity. CO augmented the cav-1/TLR4 interaction. Upon LPS stimulation, HO-1 trafficked to the caveolae by a p38 MAPK-dependent mechanism, where it down-regulated proinflammatory signaling. These results reveal an anti-inflammatory network involving cav-1 and HO-1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis
Wang, X. M., Zhang, Y., Kim, H. P., Zhou, Z., Feghali-Bostwick, C. A., Liu, F., Ifedigbo, E., Xu, X., Oury, T. D., Kaminski, N., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061536 · Cited by 397
Self-citation
Research works printed but not linked: 41
- 2004, Role of caveolae and caveolins in health and disease., 1341
- 2005, Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis., 78
- 1997, Caveolae can be alternative endocytotic structures in elicited macrophages., 19
- 2000, Involvement of cellular caveolae in bacterial entry into mast cells., 785
- 2003, Lipid rafts, caveolae, caveolin-1, and entry by Chlamydiae into host cells., 67
- 2003, Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts., C457
- 2001, Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice., 2449
- 2005, Growth factor receptors, lipid rafts and caveolae: an evolving story., 260
- 2006, Caveolin-1-deficient mice show defects in innate immunity and inflammatory immune response during Salmonella enterica serovar Typhimurium infection., 6665
- 2000, In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation., 1362
- 2006, Caveolin-1 regulates NF-kappaB activation and lung inflammatory response to sepsis induced by lipopolysaccharide., 4853
- 2002, Combined endothelial nitric oxide synthase upregulation and caveolin-1 downregulation decrease leukocyte adhesion in pial venules of ovariectomized female rats., 613
- 2006, Caveolin-1 confers antiinflammatory effects in murine macrophages via the MKK3/p38 MAPK pathway., 434
- 2002, Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation., 2603
- 2006, Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts., 2377
- 2006, A role for neutral sphingomyelinase activation in the inhibition of LPS action by phospholipid oxidation products., 1967
- 2006, Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications., 583
- 2000, Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway., 422
- 2004, Caveolae compartmentalization of heme oxygenase-1 in endothelial cells., 1080
- 1999, Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice., 1845
- 2000, Heme oxygenase activity: current methods and applications., 369
- 1997, Identification of peptide and protein ligands for the caveolin-scaffolding domain: implications for the interaction of caveolin with caveolae-associated proteins., 6525
- 1998, Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene., 2085
- 2003, Evidence for heme oxygenase-1 association with caveolin-1 and -2 in mouse mesangial cells., 525
- 1995, Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution: identification and epitope mapping of an isoform-specific monoclonal antibody probe., 16395
- 2000, Protein kinase Cα actively downregulates through caveolae-dependent traffic to an endosomal compartment., 2575
- 2006, Endotoxin tolerance attenuates LPS-induced TLR4 mobilization to lipid rafts: a condition reversed by PKC activation., 1289
- 2000, Protein kinase Cς is required for the induction of mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages., 29
- 2000, Protein kinase C plays a central role in activation of the p42/44 mitogen-activated protein kinase by endotoxin in alveolar macrophages., 4632
- 2002, Carbon monoxide modulates endotoxin-induced production of granulocyte macrophage colony-stimulating factor in macrophages., 739
- 2003, Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1., 36993
- 2005, Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo., 904
- 2001, Biphasic regulation of NF-κB activity underlies the pro- and anti-inflammatory actions of nitric oxide., 3873
- 2006, Cytokines or their antagonists for the treatment of asthma., 244
- 2006, Cytokines as targets in chronic obstructive pulmonary disease., 675
- 2006, Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis., 357
- 2006, Role of TNFα in pulmonary pathophysiology., 125
- 2006, Toll-like receptors, cytokines and the immunotherapeutics of asthma., 2365
- 2006, Mode of glucocorticoid actions in airway disease., 1750
- 2006, Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF)., 106
- 2004, Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production., 4744
Cited by
Nakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology · doi:10.1038/ni.1980 · Cited by 3,049
Self-citationNitric oxide and redox mechanisms in the immune response
Wink, D. A., Hines, H. B., Cheng, R. Y. S., Switzer, C. H., Flores-Santana, W., Vitek, M. P., Ridnour, L. A., & Colton, C. A. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.1010550 · Cited by 765
Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential
Paine, A., Eiz-Vesper, B., Blasczyk, R., & Immenschuh, S. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.014 · Cited by 699
Heme oxygenase–1, oxidation, inflammation, and atherosclerosis
Araujo, J. A., Zhang, M., & Yin, F. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00119 · Cited by 443
Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation
Ryter, S. W., & Choi, A. M. K. (2016) · Translational Research · doi:10.1016/j.trsl.2015.06.011 · Cited by 362
Self-citationIron trafficking and metabolism in macrophages: contribution to the polarized phenotype.
Cairo, G., Recalcati, S., Mantovani, A., & Locati, M. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.03.007 · Cited by 312
Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation
Chidlow, J. H., & Sessa, W. C. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq075 · Cited by 310
Heme Oxygenase-1/Carbon Monoxide: From Metabolism to Molecular Therapy
Ryter, S. W., & Choi, A. M. K. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0170tr · Cited by 308
Self-citationRyter, S. W. (2022) · Antioxidants · doi:10.3390/antiox11030555 · Cited by 271
Self-citationFessler, M. B., & Parks, J. S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100253 · Cited by 270
Abdollahi, E., Momtazi, A. A., Johnston, T. P., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25778 · Cited by 270
Heme oxygenase-1 in tumor biology and therapy
Was, H., Dulak, J., & Jozkowicz, A. (2010) · Current Drug Targets · doi:10.2174/1389450111009011551 · Cited by 259
Kang, C.-H., Choi, Y. H., Moon, S.-K., Kim, W.-J., & Kim, G.-Y. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.09.009 · Cited by 138
Strasky, Z., Zemankova, L., Nemeckova, I., Rathouska, J., Wong, R. J., Muchova, L., Subhanova, I., Vanikova, J., Vanova, K., Vitek, L., et al. (2013) · Food & Function · doi:10.1039/c3fo60230c · Cited by 87
Wada, T., Miyashita, Y., Sasaki, M., Aruga, Y., Nakamura, Y., Ishii, Y., Sasahara, M., Kanasaki, K., Kitada, M., Koya, D., et al. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00419.2013 · Cited by 79
Mitterstiller, A.-M., Haschka, D., Dichtl, S., Nairz, M., Demetz, E., Talasz, H., Soares, M. P., Einwallner, E., Esterbauer, H., Fang, F. C., et al. (2016) · Cellular Microbiology · doi:10.1111/cmi.12578 · Cited by 62
The critical roles of caveolin-1 in lung diseases
Fan, J., Zheng, S., Wang, M., & Yuan, X. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1417834 · Cited by 21
Metadata
- Authors
- Wang, X. M., Kim, H. P., Nakahira, K., Ryter, S. W., & Choi, A. M. K.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-03
- Volume
- 182
- Issue
- 6
- Pages
- 3809-3818
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1767482834
- Cited by
- 227
- References
- 2
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.